|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
23 May 2016 |
|
Main ID: |
NCT02361541 |
|
Date of registration:
|
06/02/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Determination of HCV Prevalence in a HIV Patient Cohort in Phnom Penh, Cambodia
HCV-Epi |
|
Scientific title:
|
Determination of Hepatitis C Prevalence, Genetic Diversity and Treatment Eligibility in an HIV Patient Cohort in Phnom Penh, Cambodia |
|
Date of first enrolment:
|
November 2014 |
|
Target sample size:
|
3045 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02361541 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Cross-Sectional
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Cambodia
| | | | | | | |
|
Contacts
|
|
Name:
|
Anja De Weggheleire, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Institute of Tropical Medicine, Antwerp, Belgium |
|
|
Name:
|
An Sokkab, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Sihanouk Hospital Center of HOPE (SHCH), Cambodia |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Adult (> or = 18 years old)
- Documented HIV positive
- In regular HIV care follow-up (min. 2 consultations in the last six months prior to
the study)
- Willing and able to provide written informed consent
Exclusion Criteria:
• HIV patients with currently taking Hepatitis C treatment or with a history of prior
hepatitis C treatment
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hepatitis C
|
|
HIV
|
|
Intervention(s)
|
|
Procedure: HCV screening
|
|
Primary Outcome(s)
|
|
Seroprevalence of HCV infection
[Time Frame: Baseline]
|
|
Secondary Outcome(s)
|
|
HCV diagnostic accuracy
[Time Frame: Baseline]
|
|
Proportion of HCV false-positives
[Time Frame: Baseline]
|
|
Severity of liver disease in HCV patients
[Time Frame: Baseline]
|
|
HCV genotypes
[Time Frame: Baseline]
|
|
Proportion of current HCV infection
[Time Frame: Baseline]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|